Publications by authors named "Abdulkadir Civan"
Background: To improve childhood tuberculosis (TB) diagnosis, treatment-decision algorithms (TDAs) with and without chest X-ray (CXR) were developed for children under age 10. We aimed to model diagnostic performance and costs of implementing TDAs in primary healthcare (PHC) and district hospital (DH) settings in Uganda.
Methods: We developed decision-tree models following the TDA pathway from evaluation to treatment-decision.
Article Synopsis
- In the US, the FDA takes a long time to review new drugs, which impacts costs for both drug manufacturers and patients awaiting treatment.
- Regulatory delays can influence the future R&D strategies of pharmaceutical companies, with potential consequences for drug development.
- The study shows that an additional three months of FDA review time leads to one fewer drug being developed in that category, indicating that firms can't easily transfer these costs to consumers.
We analyze the influence of technological progress on pharmaceuticals on rising health expenditures using US State level panel data. Improvements in medical technology are believed to be partly responsible for rapidly rising health expenditures. Even if the technological progress in medicine improves health outcomes and life quality, it can also increase the expenditure on health care.
View Article and Find Full Text PDF